$XXII:Pioneering Reduced-Risk Smoking with VLN® Cigarettes In the rapidly evolving tobacco industry, 22nd Century Group, Inc. ($XXII) is emerging as a pioneer with its innovative smoking alternatives. The company's flagship product, VLN® cigarettes, has gained widespread attention as the world’s first and only combustible cigarette to earn the Modified Risk Tobacco Product (MRTP) designation from the U.S. Food and Drug Administration (FDA). This recognition positions 22nd Century at the forefront of the market focused on reduced harm and safer smoking options.
VLN® Cigarettes represent a game changer in the industry, containing up to 95% less nicotine than traditional cigarettes. They are designed for adult smokers seeking to reduce nicotine intake or quit smoking altogether. The MRTP designation signifies the FDA’s acknowledgment of VLN® as a product that could benefit public health by reducing addiction risk and offering a safer smoking experience.
The company’s bold mission, "The mission is to sell the last cigarette before the 22nd Century," reflects its commitment to harm reduction and responsible tobacco use. As global trends shift towards sustainable and reduced-risk products, 22nd Century Group’s innovative approach makes it a promising contender in this market.